AMR Action Fund — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Abexxa BiologicsSep 2016SEC filingmedium confidence
BiotechArlington, US
Jon Weidanz(Director and President)Debra Weidanz(CEO and Director)
Board seatMartin Heidecker· per SEC Form D · $1.7M raise · filed Sep 2016
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.